WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 200...( SHANGHAI China Oct. 14 /Xinhua-- ...)

SHANGHAI, China, Oct. 14 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced preliminary selected unaudited financial results for the third quarter ended September 30, 2008, and updated its guidance for the full year 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

Third Quarter 2008 Preliminary Unaudited Financial Results

For the third quarter ended September 30, 2008, WuXi reports the following preliminary unaudited financial results. These results are subject to change as a result of finalization of share-based compensation expenses, closing adjustments and completion of the review process for the quarter.

Preliminary Third Quarter 2008 Financial Results

(Unaudited, U.S. Dollars in Millions)

GAAP Non-GAAP

The third quarter of The third quarter of

2008 2007 % 2008 2007 %

Growth* Growth*

Net Revenue $66.0 - 67.5 $34.0 96% $66.0 - 67.5 $34.0 96%

Laboratory

Services 46.0 - 47.0 26.7 74% 46.0 - 47.0 26.7 74%

Manufacturing

Services 20.0 - 20.5 7.3 177% 20.0 - 20.5 7.3 177%

Gross Profit 21.4 - 22.9 16.0 38% 25.9 - 27.4 16.3 63%

Laboratory

Services 18.7
'/>"/>